EGFR-HER2 inhibitor Mutated EGFR-IN-2, Purity ≥98%

Synonym: 2050906-97-1; Mutated EGFR-IN-2; SCHEMBL18586074; AKOS040733792; HY-128860; CS-0101439; EGFR-HER2 inhibitor

CAS Number: 2050906-97-1
Compound CID: 126649709

Product Size

1 mg; 5 mg; 10 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Mutated EGFR-IN-2 is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR (ex19del/T790M), EGFR (L858R/T790M), EGFR(L858R), and EGFRex19del.

Molecular Weight

562.64

Molecular Formula

C₂₉H₃₅FN₈O₃

Targets

EGFR (ex19del/T790M); EGFR (L858R/T790M): <1 nM; EGFR(L858R); EGFRex19del

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Mutated EGFR-IN-2 can be used to study its effect as a selective inhibitor of mutant EGFR in cancer treatment.

Storage

Store at -20ºC.